Michael J. Lenardo

51.7k citations

244 papers · 34.1k indexed · 14 hit papers · h-index 89

Impact in

Immunology top 0.02%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- interferon and immune responses
Cancer Research top 0.1%
- NF-κB Signaling Pathways

Papers in

Immunology 162
- Immune Cell Function and Interaction 78
- T-cell and B-cell Immunology 42
- Immunotherapy and Immune Responses 28
- Immune Response and Inflammation 22
- interferon and immune responses 21
- Immunodeficiency and Autoimmune Disorders 21
Cancer Research 47
- NF-κB Signaling Pathways 44

Co-authors: David Baltimore Lixin Zheng Jill M. Fritz Alex D. Waldman Richard M. Siegel Qian Zhang Francis Ka-Ming Chan Jin Wang
Journals: The Journal of Immunology (21 papers)Proceedings of the National Academy of Sciences (15 papers)The Journal of Experimental Medicine (13 papers)Molecular and Cellular Biology (13 papers)Science (10 papers)
Partner nations: United States United Kingdom China

In The Last Decade

Michael J. Lenardo

240 papers receiving 33.5k citations

Hit Papers

14 papers align trajectories log scale

A guide to cancer immunotherapy: from T cell basic science to clinical practice 2020 · 2.8k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Nature reviews. Immunology
2017 Cell
2010 Nature
2007 Nature Immunology
2006 Proceedings of the National Academy of Sciences
2004 Science
2002 Nature
2000 Science
1999 Annual Review of Immunology
1995 Cell
1995 Nature
1991 Nature
1989 Cell
1987 Science

Peers

Countries citing papers authored by Michael J. Lenardo

Since Specialization

Citations

This map shows the geographic impact of Michael J. Lenardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Lenardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Lenardo more than expected).

Fields of papers citing papers by Michael J. Lenardo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Lenardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Lenardo. The network helps show where Michael J. Lenardo may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael J. Lenardo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael J. Lenardo Line = papers co-authored together Michael J. Lenardo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CARD11 signaling regulates CD8+ T cell tumoricidal function Nature Immunology ·Prajwal G M, A.H. Alberga, J. V. Suneby Jagers, Song Mei, فضل ا... موموندی, S Escoffier, Liguo Han, Yi Zang, 汪长炳, Zhe He, Jtmm Cloostermans, Hecheng Li, Peng Zhang, Yan Zhang, Michael J. Lenardo, Wei Lü	2025	1
2	Pozelimab for CHAPLE disease: results from in-trial interviews and clinical outcome assessments Orphanet Journal of Rare Diseases ·Leighann Litcher‐Kelly, Ahmet Özen, Almasaula Shofi Wiridantiansi, Hagit Baris Feldman, Andrew Yaworsky, A. L. Donde, Marcin Szpernalowski, 実小田, Lorah Perlee, Sh. Zhanikulov, Е.Н. Ефременко, Michael J. Lenardo, Olivier Harari, Jessica J. Jalbert	2024	3
3	Mechanisms of antigen-induced reversal of CNS inflammation in experimental demyelinating disease Science Advances ·Jian Li, Lisen Lu, Kyle Binder, Jian Xiong, Lilin Ye, Yan Cheng, A.P. Sivertzev, Wei Lü, Jae W. Lee, Zhihong Zhang, Yuzhang Wu, Lixin Zheng, Michael J. Lenardo	2023	4
4	Early B cell factor 4 modulates FAS-mediated apoptosis and promotes cytotoxic function in human immune cells Proceedings of the National Academy of Sciences ·Satoshi Kubo, Roger Chamma, Yikun Yao, Roman Sirota, Lixin Zheng, Tovah E. Markowitz, Waipan Chan, Jian Song, Arun K. Boddapati, Keita Saeki, Björn Häupl, Ann Y. Park, Yan Cheng, Jing Cui, Thomas Oellerich, Michael J. Lenardo	2022	10
5	Homozygous IL37 mutation associated with infantile inflammatory bowel disease Proceedings of the National Academy of Sciences ·Zinan Zhang, Yu Zhang, J. W. Patton, Colin L. Sweeney, Safa Barış, Elif Karakoç-Aydıner, Yikun Yao, Deniz Ertem, Helen Matthews, Claudia Gonzaga‐Jauregui, Harry L. Malech, Helen C. Su, Ahmet Özen, Kenneth G. C. Smith, Michael J. Lenardo	2021	18
6	Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency Journal of Allergy and Clinical Immunology ·Samantha Shafer, Yikun Yao, William A. Comrie, 哲三不破, Yu Zhang, Gözde Yeşil, Elif Karakoç-Aydıner, Safa Barış, Haluk Çokuğraş, Sezin Aydemir, Ayça Kıykım, Ahmet Özen, Michael J. Lenardo	2021	11
7	A guide to cancer immunotherapy: from T cell basic science to clinical practice Nature reviews. Immunology ·Alex D. Waldman, Jill M. Fritz, Michael J. Lenardo Hit paper breakdown →	2020	2826
8	Development of immune checkpoint therapy for cancer The Journal of Experimental Medicine ·Jill M. Fritz, Michael J. Lenardo	2019	134
9	Molecular Classification of Primary Immunodeficiencies of T Lymphocytes Advances in immunology ·William A. Comrie, Michael J. Lenardo	2018	12
10	STAT5B: A Differential Regulator of the Life and Death of CD4+ Effector Memory T Cells The Journal of Immunology ·Pavel Klápště, Jill M. Fritz, Alejandro V. Villarino, Lixin Zheng, Chrysi Kanellopoulou, Benjamin Chaigne-Delalande, Juha Grönholm, Julie E. Niemela, Behdad Afzali, Matthew Biancalana, Stefania Pittaluga, Anna Jane Buckland, José L. Cohen, Steven M. Holland, John J. O’Shea, Gülbû Uzel, Michael J. Lenardo	2017	27
11	Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations Blood ·Susan Price, Pamela A. Shaw, Amy E. Seitz, Gyan Joshi, Joie Davis, Julie E. Niemela, Katie Perkins, Ronald L. Hornung, Les Folio, Philip S. Rosenberg, Jennifer M. Puck, Amy P. Hsu, Bernice Lo, Stefania Pittaluga, Elaine S. Jaffe, Thomas A. Fleisher, V. Koneti Rao, Michael J. Lenardo	2014	134
12	NF-κB activity marks cells engaged in receptor editing The Journal of Experimental Medicine ·T.N.C. Padmanabhan, Fengyi Wan, Rupesh H. Amin, Hector Nolla, Michael J. Lenardo, Mark S. Schlissel	2009	33
13	NRAS mutation causes a human autoimmune lymphoproliferative syndrome Proceedings of the National Academy of Sciences ·João Bosco Oliveira, Nicolas Bidère, Julie E. Niemela, Lixin Zheng, Keiko Sakai, B. J. Davies, Robert L. Danner, Jennifer J. Barb, Peter J. Munson, Jennifer M. Puck, Janet K. Dale, Stephen E. Straus, Thomas A. Fleisher, Michael J. Lenardo	2007	166
14	Autophagic programmed cell death by selective catalase degradation Proceedings of the National Academy of Sciences ·Li Yu, Fengyi Wan, Sudeshna Dutta, Sarah J. Welsh, Zhihua Liu, Eric C. Freundt, Eric H. Baehrecke, Michael J. Lenardo Hit paper breakdown →	2006	561
15	Regulation of an ATG7 - beclin 1 Program of Autophagic Cell Death by Caspase-8 Science ·Li Yu, Ajjai Alva, Helen C. Su, Parmesh Dutt, Eric C. Freundt, Sarah J. Welsh, Eric H. Baehrecke, Michael J. Lenardo Hit paper breakdown →	2004	1023
16	Effective Antigen-Specific Immunotherapy in the Marmoset Model of Multiple Sclerosis The Journal of Immunology ·B M Shchepotin, Adrian A. Lobito, Michele M. Johnson, Yosio Kasagi, Christina Yee, Elaine Jordan, Joseph A. Frank, Nancy Tresser, Claude P. Genain, John P. Mueller, Louis A. Matis, Michael J. Lenardo	2001	18
17	A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes European Journal of Immunology ·Francis Ka-Ming Chan, Michael J. Lenardo	2000	124
18	TNF-α-Induced Secretion of C-C Chemokines Modulates C-C Chemokine Receptor 5 Expression on Peripheral Blood Lymphocytes The Journal of Immunology ·Felicita Hornung, Giuseppe Scala, Michael J. Lenardo	2000	50
19	Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. The Journal of Immunology ·Clara M. Pelfrey, Laura R. Tranquill, Stefen A. Boehme, Henry F. McFarland, Michael J. Lenardo	1995	50
20	Interaction Between Nf-κB- and Serum Response Factor-Binding Elements Activates an Interleukin-2 Receptor α-Chain Enhancer Specifically in T Lymphocytes Molecular and Cellular Biology ·Anna A. Kuang, Kristine Novak, Sang‐Mo Kang, Kevin W. Bruhn, Michael J. Lenardo	1993	11

About Michael J. Lenardo

Michael J. Lenardo is a scholar working on Immunology, Cancer Research, Virology, Oncology and Molecular Biology, having authored 244 papers that have together received 34.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (78 papers), Cell death mechanisms and regulation (45 papers), NF-κB Signaling Pathways (44 papers), T-cell and B-cell Immunology (42 papers), Immunotherapy and Immune Responses (28 papers), Immune Response and Inflammation (22 papers), interferon and immune responses (21 papers) and Immunodeficiency and Autoimmune Disorders (21 papers). The work is most often cited by research in Immunology (17.6k citations), Cancer Research (5.1k citations), Oncology (6.5k citations), Virology (1.1k citations) and Molecular Biology (14.9k citations). Michael J. Lenardo has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include David Baltimore, Lixin Zheng, Jill M. Fritz, Alex D. Waldman, Richard M. Siegel, Qian Zhang, Francis Ka-Ming Chan, Jin Wang, Fengyi Wan and Helen C. Su. Their work appears in journals such as The Journal of Immunology, Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine, Molecular and Cellular Biology and Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact